vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Perion Network Ltd. (PERI). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $368.7M, roughly 1.3× Perion Network Ltd.). Perion Network Ltd. runs the higher net margin — 2.1% vs -10.1%, a 12.2% gap on every dollar of revenue. Perion Network Ltd. produced more free cash flow last quarter ($-2.9M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 16.4%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Perion Network Ltd. is a publicly traded advertising technology company that provides digital advertising technology solutions to advertisers, agencies, retailers, and publishers. Its core offerings are delivered through Perion One, a unified omnichannel advertising platform designed to support campaign planning, activation, optimisation, and measurement across channels and verticals including connected television (CTV), digital out-of-home (DOOH), display, video advertising, as well as retai...

CLOV vs PERI — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.3× larger
CLOV
$487.7M
$368.7M
PERI
Higher net margin
PERI
PERI
12.2% more per $
PERI
2.1%
-10.1%
CLOV
More free cash flow
PERI
PERI
$66.1M more FCF
PERI
$-2.9M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
16.4%
PERI

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CLOV
CLOV
PERI
PERI
Revenue
$487.7M
$368.7M
Net Profit
$-49.3M
$7.7M
Gross Margin
Operating Margin
-10.1%
2.0%
Net Margin
-10.1%
2.1%
Revenue YoY
44.7%
Net Profit YoY
-123.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
PERI
PERI
Q4 25
$487.7M
Q3 25
$496.6M
$368.7M
Q2 25
$477.6M
$266.5M
Q1 25
$462.3M
$157.8M
Q4 24
$337.0M
Q3 24
$331.0M
$508.9M
Q2 24
$356.3M
$323.6M
Q1 24
$346.9M
$145.2M
Net Profit
CLOV
CLOV
PERI
PERI
Q4 25
$-49.3M
Q3 25
$-24.4M
$7.7M
Q2 25
$-10.6M
$5.6M
Q1 25
$-1.3M
$11.8M
Q4 24
$-22.1M
Q3 24
$-9.2M
$78.0M
Q2 24
$7.4M
$45.2M
Q1 24
$-19.2M
$23.8M
Gross Margin
CLOV
CLOV
PERI
PERI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
PERI
PERI
Q4 25
-10.1%
Q3 25
-4.9%
2.0%
Q2 25
-2.2%
-1.7%
Q1 25
-0.3%
5.4%
Q4 24
-6.4%
Q3 24
-2.7%
15.1%
Q2 24
2.0%
13.7%
Q1 24
-6.5%
16.9%
Net Margin
CLOV
CLOV
PERI
PERI
Q4 25
-10.1%
Q3 25
-4.9%
2.1%
Q2 25
-2.2%
2.1%
Q1 25
-0.3%
7.5%
Q4 24
-6.6%
Q3 24
-2.8%
15.3%
Q2 24
2.1%
14.0%
Q1 24
-5.5%
16.4%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
PERI
PERI
Cash + ST InvestmentsLiquidity on hand
$78.3M
$156.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$722.9M
Total Assets
$541.0M
$915.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
PERI
PERI
Q4 25
$78.3M
Q3 25
$156.2M
Q2 25
$156.2M
Q1 25
$156.2M
Q4 24
$194.5M
Q3 24
$288.0M
$187.6M
Q2 24
$254.8M
$187.6M
Q1 24
$208.3M
$187.6M
Stockholders' Equity
CLOV
CLOV
PERI
PERI
Q4 25
$308.7M
Q3 25
$340.9M
$722.9M
Q2 25
$344.2M
$722.9M
Q1 25
$336.1M
$722.9M
Q4 24
$341.1M
Q3 24
$342.2M
$718.1M
Q2 24
$324.9M
$718.1M
Q1 24
$292.5M
$718.1M
Total Assets
CLOV
CLOV
PERI
PERI
Q4 25
$541.0M
Q3 25
$559.7M
$915.5M
Q2 25
$575.0M
$915.5M
Q1 25
$583.7M
$915.5M
Q4 24
$580.7M
Q3 24
$653.0M
$1.1B
Q2 24
$674.2M
$1.1B
Q1 24
$671.8M
$1.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
PERI
PERI
Operating Cash FlowLast quarter
$-66.9M
$2.6M
Free Cash FlowOCF − Capex
$-69.0M
$-2.9M
FCF MarginFCF / Revenue
-14.1%
-0.8%
Capex IntensityCapex / Revenue
0.4%
1.5%
Cash ConversionOCF / Net Profit
0.34×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
PERI
PERI
Q4 25
$-66.9M
Q3 25
$12.1M
$2.6M
Q2 25
$5.4M
Q1 25
$-16.3M
Q4 24
$34.8M
Q3 24
$50.0M
$105.2M
Q2 24
$44.8M
Q1 24
$25.9M
$17.8M
Free Cash Flow
CLOV
CLOV
PERI
PERI
Q4 25
$-69.0M
Q3 25
$11.4M
$-2.9M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
$104.7M
Q2 24
$44.4M
Q1 24
$25.5M
$17.6M
FCF Margin
CLOV
CLOV
PERI
PERI
Q4 25
-14.1%
Q3 25
2.3%
-0.8%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
20.6%
Q2 24
12.5%
Q1 24
7.3%
12.2%
Capex Intensity
CLOV
CLOV
PERI
PERI
Q4 25
0.4%
Q3 25
0.1%
1.5%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
0.1%
Q2 24
0.1%
Q1 24
0.1%
0.1%
Cash Conversion
CLOV
CLOV
PERI
PERI
Q4 25
Q3 25
0.34×
Q2 25
Q1 25
Q4 24
Q3 24
1.35×
Q2 24
6.04×
Q1 24
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

PERI
PERI

Advertising Solutions$231.4M63%
Search Advertising$137.3M37%

Related Comparisons